drugset / Trial / NCT04613180

Evaluation of the Effectiveness of Montelukast in Children With Recurrent Obstructive Bronchitis

NCT04613180

Phase 4 Unknown 100 enrolled Samarkand State Medical Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study was to evaluate the effectiveness of montelukast sodium in the treatment and prevention of recurrent obstructive bronchitis in children. The investigators examined 80 children aged 1 to 7 years with recurrent obstructive bronchitis, who were randomly divided into 2 groups.

Timeline

Start
2018-01-03
Primary completion
2023-12-30
Completion
2024-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 0.1 mg/kg Oral
Comparator Montelukast Other / unclassified 0.2 mg/kg Oral
Comparator Montelukast Other / unclassified 0.4 mg/kg Oral

Indications